Viral soluble decoy receptor as a novel treatment for IFN-I triggered diseases
Francisco Javier Alvarez-de Miranda, Isabel Alonso-Sánchez, Pilar Delgado, Antonio Santos‐Peral, Bruno Hernáez, Antonio Alcamı́
This study explores the use of viral IFN-I binding protein as a therapeutic to neutralize IFN-I and treat autoinflammatory diseases in mouse models.
bioRxiv · Aug 12, 2025 · PreprintImmunology